What is the diagnosis and treatment for prurigo (itching disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Prurigo, a chronic skin condition characterized by intensely itchy, firm nodules or papules, requires a comprehensive treatment approach to break the itch-scratch cycle and improve quality of life. The treatment of prurigo typically involves a combination of therapies, including high-potency topical corticosteroids, antihistamines, and oral medications.

  • High-potency topical corticosteroids like clobetasol 0.05% applied twice daily for 2-4 weeks can help reduce inflammation and itching, followed by maintenance therapy 1.
  • Antihistamines such as hydroxyzine (25-50mg at bedtime) or cetirizine (10mg daily) can help control itching, although sedative antihistamines may predispose to dementia and should be avoided, except in palliative care 1.
  • Oral medications like gabapentin (starting at 300mg daily, gradually increasing) or pregabalin (75mg twice daily) may be prescribed for severe cases, although gabapentin should not be used in hepatic pruritus 1.
  • Newer treatments include dupilumab injections (300mg every two weeks) for refractory cases.
  • Patients should avoid scratching, keep nails short, use gentle fragrance-free soaps, apply moisturizers regularly, and wear loose cotton clothing.
  • Underlying conditions such as iron deficiency, lymphoma, polycythaemia vera, solid cancers, uraemia, liver disease, neuropathy, and psychological and emotional factors should be addressed and treated accordingly, as they can contribute to the development and persistence of prurigo 1. The most effective treatment approach for prurigo involves a combination of therapies tailored to the individual's symptoms and response, with a focus on breaking the itch-scratch cycle and improving quality of life.

From the FDA Drug Label

Triamcinolone acetonide cream, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Triamcinolone cream is indicated for the relief of pruritic manifestations of corticosteroid-responsive dermatoses, which includes prurigo.

  • The drug is used to relieve inflammatory and pruritic symptoms.
  • Prurigo is a condition characterized by intense pruritus (itching), which may be relieved by triamcinolone cream 2.

From the Research

Definition and Characteristics of Prurigo

  • Prurigo is a condition characterized by nodular cutaneous lesions that itch intensely 3
  • It can be caused by various factors, including insect stings, toxic agents, parasites, bacteria, or topically or orally administered drugs 3
  • Prurigo is sometimes associated with atopy, pregnancy, internal diseases, malabsorption, or malignancy 3
  • Emotional factors can also influence the perception of itch and induce prurigo by provoking scratching 3

Classification and Types of Prurigo

  • Prurigo can be classified into different types, including prurigo nodularis, prurigo chronica multiformis, and prurigo (not otherwise specified) 4
  • The temporal classification includes acute/subacute and chronic disease (≥ 6 weeks), with different clinical variants, synonymies, and underlying etiological factors 5
  • Prurigo pigmentosa is a specialized form of prurigo that has some ethnic preference 3

Treatment Options for Prurigo

  • Topical treatments, such as corticosteroids, coal tar, bath photochemotherapy, UVB, cryotherapy, or capsaicin, can be used to treat prurigo 3
  • Systemic regimens, involving use of psoralen + UVA (PUVA), erythromycin, arotinoid acid, cyclosporine, chloroquine, dapsone, minocycline, naltrexone, azathioprine, or thalidomide, can also be used 3
  • Non-systemic forms of treatment, including topical corticosteroids, topical steroid-sparing agents, and phototherapy, can be effective for prurigo nodularis 6
  • Duloxetine hydrochloride, a serotonin-norepinephrine reuptake inhibitor, has been shown to be useful for treating prurigo via modulating itch signals and immune responses 7

Immunological Basis of Prurigo

  • The immunology of chronic prurigo shows similarities with atopic dermatitis due to the involvement of IL-4 and IL-13, IL-22, and IL-31 5
  • At least 50% of patients with chronic prurigos have atopic diathesis, which can influence the treatment and outcome of the disease 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prurigo: diagnosis and management.

American journal of clinical dermatology, 2004

Research

2020 guidelines for the diagnosis and treatment of prurigo.

The Journal of dermatology, 2021

Research

Prurigo: review of its pathogenesis, diagnosis, and treatment.

Anais brasileiros de dermatologia, 2024

Research

Prurigo successfully treated with duloxetine hydrochloride.

The Australasian journal of dermatology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.